Pseudorabies
Pseudorabies is a disease of swine that is caused by the Suid herpesvirus 1 (SuHV1), also known as Aujeszky's disease or mad itch. This disease is not related to rabies and the term "pseudorabies" is a misnomer. It is a viral disease that is infectious and can affect mammals, including humans. However, it is not a zoonotic disease, meaning it cannot be transmitted from animals to humans.
Symptoms[edit]
The symptoms of pseudorabies vary depending on the age of the pig. In newborn piglets, the disease is usually fatal and can cause symptoms such as trembling, excessive salivation, and convulsions. In older pigs, the symptoms can include fever, weight loss, respiratory distress, and neurological signs.
Transmission[edit]
Pseudorabies is primarily transmitted through direct contact with infected pigs. The virus can also be spread through the air, and can survive in the environment for a short period of time. The virus can also be spread through contaminated feed or water.
Diagnosis[edit]
Diagnosis of pseudorabies is based on clinical signs and laboratory testing. The virus can be detected in blood, saliva, nasal secretions, and tissues from affected pigs. The most common tests used for diagnosis are the virus isolation and the polymerase chain reaction (PCR) test.
Treatment and Prevention[edit]
There is no specific treatment for pseudorabies. Management of the disease involves supportive care and prevention of secondary infections. Vaccination is the most effective method of prevention. Biosecurity measures, such as isolation of infected pigs and disinfection of facilities, are also important in preventing the spread of the disease.
See Also[edit]
References[edit]
-
Distribution of Pseudorabies in Wild Swine in the USA
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
